Limited coverage drugs – voriconazole

Last updated on October 19, 2022

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	Strength	Form
voriconazole	50 mg, 200 mg	tablet
voriconazole	200 mg	injection

Criteria	Approval period
For continuation of hospital-initiated treatment of invasive aspergillosis OR For continuation of hospital-initiated treatment of culture-proven invasive candidiasis with documented resistance to fluconazole.	3 months

Criteria

Approval period

For continuation of hospital-initiated treatment of invasive aspergillosis

For continuation of hospital-initiated treatment of culture-proven invasive candidiasis with documented resistance to fluconazole.

3 months

Practitioner exemptions

None

Special notes

PharmaCare does not provide coverage for community-initiated treatment of invasive aspergillosis associated with HIV.

Special Authority requests

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – voriconazole

Practitioner exemptions

Special notes

Special Authority requests